News conference to announce San Antonio cancer research grant and to preview the 2010 NCAA® Women’s Final Four®

WHAT: “100 Days Out” news conference that will include a substantial cancer research grant announcement by the Kay Yow/Women’s Basketball Coaches Association Cancer Fund and the V Foundation to support breast cancer research at the Cancer Therapy & Research Center at the UT Health Science Center. Conference will also preview the 2010 NCAA Women’s Final Four to be held April 4 and 6 at the Alamodome.

WHEN: Wednesday, December 9, 2009
2:00 – 2:45 p.m.

WHERE: Henry B. Gonzalez Convention Center Patio-of-States
Adjacent to the corner of Market and Alamo Streets
Rain location: The Convention Center Gallery
Media parking will be available using the bagged meter spaces across Market Street

WHO: National event spokesperson: Sue Donohoe, Vice President, NCAA Division I Women’s Basketball

San Antonio event spokesperson: Cyndi Taylor Krier, Local Organizing Committee, 2010 NCAA Women’s Final Four

Grantor: Nick Valvano, Chief Executive Officer, The V Foundation for Cancer Research

Grantor: Marsha Sharp, Executive Director, Kay Yow/WBCA Cancer Fund

Grant recipient: Dr. Rajeshwar Rao Tekmal, Professor of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio

WHY: The 2010 Women’s Final Four will be played in San Antonio in approximately 100 days. In addition to the announcement of a substantial grant for further cancer research in San Antonio, this news conference will preview the many fan interactive events which the San Antonio community can take advantage of as part of one of America’s prestigious women’s championship sporting events.

The Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio is one of the nation’s leading academic research and treatment centers, serving more than 4.4 million people in the high-growth corridor of Central and South Texas including Austin, San Antonio, Laredo and the Rio Grande Valley. CTRC is one of the elite cancer centers in the country to be named a National Cancer Institute-designated Cancer Center, and is one of the only three in Texas. A world leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development is internationally recognized for conducting one of the largest oncology Phase I clinical drug programs in the world, and participates in the clinical and/or preclinical development of many of the cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit

Share This Article!